This certification, awarded under the GC-Mark® program and verified by the international organization DQS CFS GmbH (German Association for Sustainability), confirms that the company strictly complies with the guidelines of the European Medicines Agency (EMA) for materials of plant origin.

The renewal of our GACP certification (Registration No. 30350601 GC) validates that every stage of our agricultural and harvesting process is carried out under the highest international standards. This guarantees:

• Consistent Quality: Compliance with GACP standards ensures that medicinal cannabis plants are grown and harvested following standardized procedures that guarantee the reproducibility of the raw material.

• Pharmaceutical safety: By aligning with EMA requirements, Cannava ensures that the plant material is free of contaminants and maintains the integrity of its active ingredients, essential for the production of effective and safe end products.

• Sustainability and traceability: As members of the IQNET network, our processes are independently audited, ensuring total transparency from seed to harvest.

At Cannava, we understand that the quality of the final product begins in the soil. Therefore, our cultivation operations are governed by a comprehensive management system that prioritizes environmental and technical control. This GACP certification is the cornerstone that allows us to move towards producing active pharmaceutical ingredients (APIs) of exceptional purity.

With this renewal, valid until February 2027, Cannava reaffirms its commitment to continue leading the medicinal cannabis industry in Argentina, bringing health and wellness with scientific backing and international validation.